Koizumi M, Motegi K, Umeda T. 「A novel biomarker, active whole skeletal total lesion glycolysis (WS-TLG), as a quantitative method to measure bone metastatic activity in breast cancer patients.」Ann Nucl Med.

Koizumi M, Motegi K, Umeda T.「A novel biomarker, active whole skeletal total lesion glycolysis (WS-TLG), as a quantitative method to measure bone metastatic activity in breast cancer patients.」Ann Nucl Med. 2019 Apr 13.

https://www.ncbi.nlm.nih.gov/pubmed/30982124